Formulations of RBP4 inhibitors and methods of use
US11951100B2 · kind B2 · utility
0Cited by
17References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2023 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Sep 1, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as macular degeneration and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.